These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
217 related articles for article (PubMed ID: 19849847)
1. Loss of prostasin (PRSS8) in human bladder transitional cell carcinoma cell lines is associated with epithelial-mesenchymal transition (EMT). Chen LM; Verity NJ; Chai KX BMC Cancer; 2009 Oct; 9():377. PubMed ID: 19849847 [TBL] [Abstract][Full Text] [Related]
2. Ibuprofen regulates the expression and function of membrane-associated serine proteases prostasin and matriptase. Chai AC; Robinson AL; Chai KX; Chen LM BMC Cancer; 2015 Dec; 15():1025. PubMed ID: 26715240 [TBL] [Abstract][Full Text] [Related]
3. Evaluation of thymosin β4 in the regulation of epithelial-mesenchymal transformation in urothelial carcinoma. Wang ZY; Zeng FQ; Zhu ZH; Jiang GS; Lv L; Wan F; Dong R; Xiao XY; Xing SA Urol Oncol; 2012; 30(2):167-76. PubMed ID: 20864366 [TBL] [Abstract][Full Text] [Related]
4. Transitional cell carcinomas and nonurothelial carcinomas of the urinary bladder differ in the promoter methylation status of the caveolin-1, hDAB2IP and p53 genes, but not in the global methylation of Alu elements. Kunze E; Von Bonin F; Werner C; Wendt M; Schlott T Int J Mol Med; 2006 Jan; 17(1):3-13. PubMed ID: 16328005 [TBL] [Abstract][Full Text] [Related]
5. Protein expression and gene promoter hypermethylation of CD99 in transitional cell carcinoma of urinary bladder. Xuan Y; Kim S; Lin Z J Cancer Res Clin Oncol; 2011 Jan; 137(1):49-54. PubMed ID: 20217126 [TBL] [Abstract][Full Text] [Related]
6. Prostasin serine protease inhibits breast cancer invasiveness and is transcriptionally regulated by promoter DNA methylation. Chen LM; Chai KX Int J Cancer; 2002 Jan; 97(3):323-9. PubMed ID: 11774283 [TBL] [Abstract][Full Text] [Related]
7. Promoter hypermethylation of the 14-3-3 sigma, SYK and CAGE-1 genes is related to the various phenotypes of urinary bladder carcinomas and associated with progression of transitional cell carcinomas. Kunze E; Wendt M; Schlott T Int J Mol Med; 2006 Oct; 18(4):547-57. PubMed ID: 16964403 [TBL] [Abstract][Full Text] [Related]
8. Clinical implications of the expression of epidermal growth factor receptors in human transitional cell carcinoma. Messing EM Cancer Res; 1990 Apr; 50(8):2530-7. PubMed ID: 1690599 [TBL] [Abstract][Full Text] [Related]
9. Regulation of prostasin expression and function in the prostate. Chen LM; Zhang X; Chai KX Prostate; 2004 Apr; 59(1):1-12. PubMed ID: 14991861 [TBL] [Abstract][Full Text] [Related]
10. Expression of chicken ovalbumin upstream promoter-transcription factor I (COUP-TFI) in bladder transitional cell carcinoma. Ham WS; Lee JH; Yu HS; Choi YD Urology; 2008 Oct; 72(4):921-6. PubMed ID: 18387660 [TBL] [Abstract][Full Text] [Related]
11. Treatment with low-dose interferon-alpha restores the balance between matrix metalloproteinase-9 and E-cadherin expression in human transitional cell carcinoma of the bladder. Slaton JW; Karashima T; Perrotte P; Inoue K; Kim SJ; Izawa J; Kedar D; McConkey DJ; Millikan R; Sweeney P; Yoshikawa C; Shuin T; Dinney CP Clin Cancer Res; 2001 Sep; 7(9):2840-53. PubMed ID: 11555602 [TBL] [Abstract][Full Text] [Related]
12. Urinary bladder transitional cell carcinogenesis is associated with down-regulation of NF1 tumor suppressor gene in vivo and in vitro. Aaltonen V; Boström PJ; Söderström KO; Hirvonen O; Tuukkanen J; Nurmi M; Laato M; Peltonen J Am J Pathol; 1999 Mar; 154(3):755-65. PubMed ID: 10079253 [TBL] [Abstract][Full Text] [Related]
13. Multiple mechanisms downregulate CDKN1C in human bladder cancer. Hoffmann MJ; Florl AR; Seifert HH; Schulz WA Int J Cancer; 2005 Apr; 114(3):406-13. PubMed ID: 15551363 [TBL] [Abstract][Full Text] [Related]
14. The differential expression of EphB2 and EphB4 receptor kinases in normal bladder and in transitional cell carcinoma of the bladder. Li X; Choi WW; Yan R; Yu H; Krasnoperov V; Kumar SR; Schuckman A; Klumpp DJ; Pan CX; Quinn D; Gill IS; Gill PS; Liu R PLoS One; 2014; 9(8):e105326. PubMed ID: 25148033 [TBL] [Abstract][Full Text] [Related]
15. Methylation of tumour suppressor genes APAF-1 and DAPK-1 and in vitro effects of demethylating agents in bladder and kidney cancer. Christoph F; Kempkensteffen C; Weikert S; Köllermann J; Krause H; Miller K; Schostak M; Schrader M Br J Cancer; 2006 Dec; 95(12):1701-7. PubMed ID: 17133271 [TBL] [Abstract][Full Text] [Related]
16. Bladder Tumor Subtype Commitment Occurs in Carcinoma Wullweber A; Strick R; Lange F; Sikic D; Taubert H; Wach S; Wullich B; Bertz S; Weyerer V; Stoehr R; Breyer J; Burger M; Hartmann A; Strissel PL; Eckstein M Cancer Res; 2021 Mar; 81(6):1552-1566. PubMed ID: 33472889 [TBL] [Abstract][Full Text] [Related]
18. Hypermethylation of an E-cadherin (CDH1) promoter region in high grade transitional cell carcinoma of the bladder comprising carcinoma in situ. Horikawa Y; Sugano K; Shigyo M; Yamamoto H; Nakazono M; Fujimoto H; Kanai Y; Hirohashi S; Kakizoe T; Habuchi T; Kato T J Urol; 2003 Apr; 169(4):1541-5. PubMed ID: 12629411 [TBL] [Abstract][Full Text] [Related]
19. Epigenetic inactivation of KLF4 is associated with urothelial cancer progression and early recurrence. Li H; Wang J; Xiao W; Xia D; Lang B; Wang T; Guo X; Hu Z; Ye Z; Xu H J Urol; 2014 Feb; 191(2):493-501. PubMed ID: 24018236 [TBL] [Abstract][Full Text] [Related]
20. Long-term exposure to cigarette smoke extract induces hypomethylation at the RUNX3 and IGF2-H19 loci in immortalized human urothelial cells. Chen LM; Nergard JC; Ni L; Rosser CJ; Chai KX PLoS One; 2013; 8(5):e65513. PubMed ID: 23724145 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]